Faculty Bibliography

BACKGROUND CONTEXT: Surgeons may preferentially limit fusion levels for younger vs older ASD patients to maintain motion segments and optimize postoperative function. Few data exist comparing the functional impact of upper thoracic (UT) vs thoracolumbar (TL) upper instrumented vertebra (UIV) in younger vs older ASD patients undergoing long fusion to the pelvis. PURPOSE: Evaluate patient reported functional impact of UT vs TL UIV in younger vs older ASD patients undergoing long fusion to the pelvis. STUDY DESIGN/SETTING: Propensity score matched (PSM) analysis of ASD patients prospectively enrolled into a multicenter study. PATIENT SAMPLE: Surgically treated ASD patients prospectively enrolled into multicenter study. OUTCOME MEASURES: Numeric rating scale (NRS) back and leg pain, Scoliosis Research Society-22r questionnaire (SRS-22r), Short Form-36v2 questionnaire (SF-36), Oswestry Disability Index (ODI), estimated blood loss, duration of hospital stay, postoperative complications, revision spine surgery.
METHOD(S): Surgically treated ASD patients prospectively enrolled into a multicenter ASD study were divided into 2 age groups (younger= <65 years, older= > 65 years) and separated according to UIV (TL= L2-T7; UT= T6-T1). Study inclusion criteria; 1) surgery for Lumbar (L), Sagittal (S), or Mixed (M) deformities (as per SRS-Schwab ASD classification), 2) fusion to the pelvis, 3) minimum 5 levels fused, and 4) minimum 2 year postop follow up. Surgery for double major or thoracic scoliosis were excluded. PSM was used to match preop patient demographics, scoliosis, and sagittal spinopelvic parameters including PI-LL, TK, SVS, and TPA. Surgical data evaluated and impact of UIV upon patient reported functional outcomes compared for UT vs TL for younger vs older.
RESULT(S): From 2008-2018, 435 of 717 eligible surgically treated patients were evaluated; younger (n=193; mean age 57.6 years) and older (n=242; mean age 72.3 years), mean levels fused UT=17.4, TL=10.7 (p<0.05). Preop spine deformity, demographics, and performance of osteotomies were similar for matched UT vs TL in younger and older (p>0.05). Surgical blood loss, duration of SICU and hospital stay was greater for UT vs TL in younger and older (p<0.05). UT had more revision surgery than TL due to implant failures in younger (20% vs 3%) and older (16% vs 1%), respectively (p<0.05). Older UT had more major complications than older TL (65% vs 30%). At minimum 2 year postoperative follow up spine deformity correction and all PROMs (including improvements and final values) including SRS-22r activity, SF-36 physical function, SF-36 role physical, SF-36 social function and SF-36 vitality were similar UT vs TL in younger and older (p>0.05).
CONCLUSION(S): Younger ASD patients fused to the pelvis do not report more physical restrictions for UT vs TL UIV compared to older ASD patients, however blood loss, SICU and hospital stay and complications were greater for UT vs TL in younger and older cohorts. When deciding upon UIV for ASD patients, the minimal impact of UT vs TL UIV upon patient reported outcomes must be offset by cognizance of a longer hospital stay and potential for greater postoperative complications for UT fusions especially in older patients. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Reoperations following adult spinal deformity (ASD) surgery place a significant burden on patient quality of life and overall health care costs. Despite the common knowledge of frequently occurring complications following ASD surgery that require reoperation, little is known on the cost and timing of these complications. Attempts to optimize the cost effectiveness of ASD surgery requires careful examination of the overall impact, frequency and timing of complications requiring reoperation on total cost of care. PURPOSE: The primary aim of our study was to ascertain the percentage of total cost of care attributed to reoperations, identify the costliest complications requiring reoperation following index surgery and to determine the timing of these complications. STUDY DESIGN/SETTING: Retrospective analysis of a prospective, multicenter study. PATIENT SAMPLE: ASD patients with >4 level fusion and eligible for minimum 2-year follow-up were included. OUTCOME MEASURES: Reoperation rates, Total cost of care.
METHOD(S): ASD patients with >4 level fusion with 2-year follow-up were included. Index and total episode of care (EOC) costs were calculated using Medicare's inpatient prospective payment system (IPPS) for MS-DRGs 453-460 and adjusted for inflation to 2020 real dollars. QALYs gained were calculated using baseline, 1-year, and 2-year SF-6D scores. Complication categories included: PJK (proximal junctional kyphosis), adjacent segment disease, pseudarthrosis, neurologic complications, malignment, implant malposition, and infections.
RESULT(S): DRG data for index and revision surgery was available for 505/889 patients. Mean age was 62.5+12.4 years, 76% women. Eighty-nine patients (18%) required a total of 114 reoperations (range 1-5 per patient). The mean index EOC for the whole cohort was $72,718, compared to a mean cost of $59,130 for each reoperation. Accounting for all reoperations, the tEOC in the revision group was 2.1-times higher than the non-revision group ($151,913 vs $71,978, p<0.0001). The 2-year QALY gain in the revision group was significantly higher than the non-revision group (0.08 vs 0.03, p<0.01). The two most common complications requiring reoperations were PJK (41.2%) and pseudarthrosis (36.8%). Reoperations for PJK and pseudoarthrosis collectively accounted for 77% of reoperation costs, but the majority (53%) occurred after 2 years of index surgery. Infections, implant malposition, or neurologic complications (33% each) were most common requiring reoperations within 30 days of index surgery.
CONCLUSION(S): PJK and pseudarthrosis were the two most common complications requiring reoperation and most occurred most frequently over 2 years after index surgery. Collectively, they contributed to 77% of the total reoperation costs. Efforts to optimize the cost effectiveness of ASD surgery should focus on effective methods to mitigate risk of PJK and pseudarthrosis. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Preoperative opioid consumption, poor mental health, and lower socioeconomic status are each associated with worse surgical outcomes for adult spinal deformity (ASD). Little data exits evaluating preoperative morphine milligram equivalent (MME) consumption and preoperative mental health, social function, and socioeconomic status in ASD. PURPOSE: Evaluate the correlations between preoperative daily MME consumption and preoperative depression, anxiety, mental health scores, and socioeconomic status for ASD patients prior to receiving reconstructive ASD surgery. We hypothesized that preoperative MME consumption correlates with preoperative depression, anxiety, poor mental health, poor social function, and poor socioeconomic status in ASD. STUDY DESIGN/SETTING: Preoperative analysis of ASD patients prospectively enrolled into a multicenter study. PATIENT SAMPLE: ASD patients prospectively enrolled into multicenter study. OUTCOME MEASURES: Numeric rating scale (NRS) back and leg pain, Scoliosis Research Society-22r questionnaire (SRS-22r), Edmonton Frailty Index (EFI score), grip strength, Veterans Rand Health Questionnaire (VR-12), Oswestry Disability Index (ODI), daily morphine milligram equivalent consumption (MME), PROMIS-Pain Interference (PROMIS-PI), PROMIS-Physical Function (PROMIS-PF), PROMIS-Depression (DEP), PROMIS-Anxiety (ANX), PROMIS-Satisfaction with Social Roles (SR) and PROMIS-Satisfaction with Discretionary Social Activities (SDA) computer adaptive tests (CATs), Area Deprivation Index (ADI) scores.
METHOD(S): From 2018-2020, ASD patients were prospectively enrolled into a multicenter study. Preoperative MME was calculated. Preoperative PROMIS-DEP, PROMIS-ANX, PROMIS=SR, PROMIS-SDA, PROMIS-PI and PF, SRS-22r total and domain scores, and VR-12 mental component summary (MCS) were calculated. ADI scores were collected to assess socioeconomic status, as previously described. MME data were log transformed and two-tailed Pearson correlation coefficients calculated. Correlation strengths were interpreted according to Cohen. Confidence intervals were created with 1,000 sample bootstrapping.
RESULT(S): A total of 207/207 patients enrolled were evaluated; mean age 61 years (18-81). Preoperative opioid consumption was reported in 38% patients (n=78; mean preoperative MME 22.5 mg, range 1-420 mg). Preoperative MME did not correlate with PROMIS-ANX (p=0.07) and did not correlate with socioeconomic status (ADI; p=0.37). Preoperative MME showed small correlations with PROMIS-DEP (r=0.2, p=0.01), VR-12 MCS (r=-.2, p=0.002), and SRS-Mental Health (r=-0.2, p=0.005). Preoperative MME showed moderate correlations with PROMIS-PI (r=0.4, p<0.0001), PROMIS-PF (r=-0.4, p<0.0001), SRS-Pain (r=-0.5, p<0.0001), SRS-Function (r=-0.4, p<0.0001), PROMIS-SR (r=-0.3, p<0.0001) and PROMIS-SSA (r=-0.4, p<0.0001).
CONCLUSION(S): Prospective evaluation of 207 ASD patients demonstrated minimal to no correlations between preoperative MME consumption and preoperative anxiety, depression or low socioeconomic status. Preoperative MME consumption demonstrated moderate correlations with preoperative pain, physical function, and social function scores. The negative impacts of opioid consumption on physical measures are likely independent of psychosocial variables in ASD. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Deterioration of global coronal alignment (GCA) may be associated with worse outcomes after adult spinal deformity (ASD) surgery. The impact of fusion length and upper instrumented vertebra (UIV) selection for patients with this complication is unclear. PURPOSE: Our objective was to compare outcomes for long sacropelvic fusions with upper-thoracic (UT) vs lower-thoracic (LT) UIV in patients with worsening GCA>=1cm. STUDY DESIGN/SETTING: Retrospective review of a prospectively collected multicenter case registry. PATIENT SAMPLE: Database enrollment required age >=18 years, scoliosis >=20degree, sagittal vertical axis (SVA) >=5cm, pelvic tilt >=25degree, or thoracic kyphosis >=60degree. OUTCOME MEASURES: Radiographic alignment, HRQL (Oswestry Disability Index [ODI], Short Form-36 [SF-36], Scoliosis Research Society-22 [SRS-22r], numerical rating scale [NRS] back/leg pain scores), and complications.
Method(s): This is a retrospective analysis of a prospective multicenter database of consecutive ASD patients. Index operations involved instrumented fusion from sacropelvis to thoracic spine. Global coronal deterioration was defined as worsening GCA>=1cm from preoperative to 2-year follow-up.
Result(s): Of 875 potentially eligible patients, 560 (64%) had complete 2-year follow-up data, of which 144 (25.7%) demonstrated worse GCA at 2-year postop (UT 35.4%, LT 64.6%). At baseline, UT had younger age (61.6+/-9.9 vs 64.5+/-8.6years, p=0.008), more osteoporosis (35.3% vs 16.1%, p=0.009), and worse scoliosis (51.9+/-22.5degree vs 32.5+/-16.3degree, p<0.001). Index operations were comparable except UT had longer fusions (16.4+/-0.9 vs 9.7+/-1.2 levels, p<0.001) and operative duration (8.6+/-3.2 vs 7.6+/-3.0hrs, p=0.023). At 2-year follow-up, global coronal deterioration averaged 2.7+/-1.4cm (1.9 to 4.6cm, p<0.001), scoliosis improved (39.3+/-20.8degree to 18.0+/-14.8degree, p<0.001), and sagittal spinopelvic alignment improved significantly for all patients. UT maintained smaller positive C7-sagittal vertical axis (SVA) (2.7+/-5.7 vs 4.7+/-5.7cm, p=0.014). Postoperative 2-year health-related quality-of-life (HRQL) was significantly improved from baseline for all patients. Significant HRQL comparisons included: UT had worse SRS-22r Activity (3.2+/-1.0 vs 3.6+/-0.8, p=0.040) and SRS-22r Satisfaction (3.9+/-1.1 vs 4.3+/-0.8, p=0.021). Also, fewer UT patients improved by >=1 minimal clinically important difference in leg pain NRS (41.3% vs 62.7%, p=0.020). Total reported complications (total=208, reoperation=53/major=77/minor=78) had comparable percentages of affected UT vs LT patients, but the percentage of re-operated patients was higher for UT (35.3% vs 18.3%, p=0.023). UT had higher reoperation rates for rod fracture (13.7% vs 2.2%, p=0.006), pseudarthrosis (7.8% vs 1.1%, p=0.006), but not proximal junctional kyphosis (9.8% vs 8.6%, p=0.810).
Conclusion(s): In ASD patients with worse 2-year GCA after long sacropelvic fusion, upper-thoracic UIV was associated with worse 2-year HRQL compared to lower-thoracic UIV. This may suggest residual global coronal malalignment is clinically less tolerated in ASD patients with longer fusions to proximal thoracic spine. These results can inform operative planning and improve patient counseling. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Concerns exist regarding disease transmission and cost associated with postoperative nonroutine discharge. Few data exist evaluating impact of nonroutine vs home discharge on readmissions, complications and patient reported outcome measures (PROMs) for adult spinal deformity (ASD) surgery. PURPOSE: Evaluate 30-day readmissions, 90-day return to surgery, postoperative complications, and postoperative PROMs for matched ASD patients receiving nonroutine discharge vs home discharge following surgery. STUDY DESIGN/SETTING: Propensity score matched (PSM) analysis of ASD patients prospectively enrolled into a multicenter study. PATIENT SAMPLE: Surgically treated ASD patients prospectively enrolled into multicenter study. OUTCOME MEASURES: Numeric rating scale (NRS) back and leg pain, Scoliosis Research Society-22r questionnaire (SRS-22r), Short Form-36v2 questionnaire (SF-36), Oswestry Disability Index (ODI), duration of hospital stay, 30-day readmission, 90-day return to surgery, postoperative complications.
METHOD(S): Surgically treated ASD patients prospectively enrolled in a multicenter ASD study were divided into two discharge disposition groups, nonroutine (NON) and home (HOME). NON was further divided into acute rehab (REHAB) or skilled nursing facility (SNF) discharge. Study inclusion criteria; (1) surgery >=5 levels fused, (2) >=2-year follow-up. PSM was used to match NON vs HOME for age, frailty and total levels fused. 30-day hospital readmission, 90-day return to surgery, postoperative complications, one and minimum 2 year PROM data was compared for NON vs HOME, and REHAB vs SNF vs HOME.
RESULT(S): From 2015 to 2019, 241 of 374 eligible treated patients were evaluated and 158 included in this study after PSM (mean 2.7 year follow-up). NON (n=106) and HOME (n=52) had similar age (67.6 vs 67.6 years), ASD-frailty index (3.9 vs 3.9), levels fused at surgery (13.8 vs 13.7), and preop PROMs, respectively (p>0.05). Duration of hospital stay (9.7 vs 10.4 days), 30-day readmission (6.6% vs 6.6%), 90-day return to surgery (9.4% vs10.4%), total complications/patient (2.0 vs 1.5), major complications/patient (0.8 vs 0.5), were similar NON vs HOME, respectively (p>0.05). At last follow-up, HOME demonstrated better ODI (21.6 vs 28.2), SRS-total (3.8 vs 3.5), and SRS-activity (3.7 vs 3.3) than NON, respectively (p<0.05). Sub-analysis of REHAB (N=63) vs SNF (N=41) vs HOME showed similar findings, including similar 30-day readmissions, 90-day return to surgery, and complications (p>0.05) and improved PROMs for HOME vs REHAB and SNF (p<0.05).
CONCLUSION(S): Analysis of 158 operatively treated ASD patients prospectively enrolled into a multicenter study and matched for age, frailty, and surgery performed demonstrated that postoperative discharge to skilled nursing or acute rehab facilities did not reduce 30-day readmissions, 90-day return to surgery, or postoperative complications. At one and minimum two years postop, patients discharged home had better PROMs scores than nonroutine discharge. These data should be considered in conjunction with postoperative needs and the cost and disease transmission risks for nonroutine discharge. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

OBJECTIVE:To prioritize the cervical parameter targets for alignment. METHODS:Included: cervical deformity (CD) patients (C2-7 Cobb angle > 10°, cervical lordosis > 10°, cervical sagittal vertical axis [cSVA] > 4 cm, or chin-brow vertical angle > 25°) with full baseline (BL) and 1-year (1Y) radiographic parameters and Neck Disability Index (NDI) scores; patients with cervical [C] or cervicothoracic [CT] Primary Driver Ames type. Patients with BL Ames classified as low CD for both parameters of cSVA ( < 4 cm) and T1 slope minus cervical lordosis (TS-CL) ( < 15°) were excluded. Patients assessed: meeting minimum clinically important differences (MCID) for NDI ( < -15 ΔNDI). Ratios of correction were found for regional parameters categorized by primary Ames driver (C or CT). Decision tree analysis assessed cutoffs for differences associated with meeting NDI MCID at 1Y. RESULTS:Seventy-seven CD patients (mean age, 62.1 years; 64% female; body mass index, 28.8 kg/m2). Forty-one point six percent of patients met MCID for NDI. A backwards linear regression model including radiographic differences as predictors from BL to 1Y for meeting MCID for NDI demonstrated an R2 of 0.820 (p = 0.032) included TS-CL, cSVA, McGregor's slope (MGS), C2 sacral slope, C2-T3 angle, C2-T3 SVA, cervical lordosis. By primary Ames driver, 67.5% of patients were C, and 32.5% CT. Ratios of change in predictors for MCID NDI patients for C and CT were not significant between the 2 groups (p > 0.050). Decision tree analysis determined cutoffs for radiographic change, prioritizing in the following order: ≥ 42.5° C2-T3 angle, > 35.4° cervical lordosis, < -31.76° C2 slope, < -11.57-mm cSVA, < -2.16° MGS, > -30.8-mm C2-T3 SVA, and ≤ -33.6° TS-CL. CONCLUSION/CONCLUSIONS:Certain ratios of correction of cervical parameters contribute to improving neck disability. Prioritizing these radiographic alignment parameters may help optimize patient-reported outcomes for patients undergoing CD surgery.

BACKGROUND CONTEXT: Few guidelines exist regarding appropriate upper instrumented vertebra (UIV) selection for adult spinal deformity (ASD) patients undergoing long fusion to the pelvis. Fusion to upper thoracic (UT) spine may provide greater deformity correction and reduce proximal junctional failure (PJF) rates compared to fusions terminating at the thoracolumbar (TL) spine. Previous reports comparing outcomes for UT vs TL UIV for ASD surgery are confounded by discrepant patient cohorts. PSM analyses can be used to reduce selection bias and mimic patient randomization. PURPOSE: Use a propensity score matched (PSM) analysis to compare surgical and hospital data, deformity correction, complication rates, and patient reported outcomes (PROs) for demographically and radiographically matched ASD patients receiving TL vs UT UIV. STUDY DESIGN/SETTING: PSM analysis of ASD patients prospectively enrolled into a multicenter study. PATIENT SAMPLE: Surgically treated ASD patients. OUTCOME MEASURES: Numeric rating scale (NRS) back and leg pain, Scoliosis Research Society-22r questionnaire (SRS-22r), Short Form-36v2 questionnaire (SF-36), Oswestry Disability Index (ODI), estimated blood loss, duration of hospital stay, postoperative complications, revision spine surgery, PJF.
Method(s): ASD patients prospectively enrolled into a multicenter study from 2009-2018 were classified according to SRS-Schwab ASD Types. Study inclusion; 1) surgery for lumbar (L), sagittal (S) or mixed (M) deformities, 2) fusion to pelvis, 3) >=5 levels fused, 4) >=2 year follow up. Study exclusion; double major or thoracic scoliosis, thoracic hyperkyphosis (>70degree). UIV cohorts formed based on bimodal UIV distribution (TL=L2-T8 vs UT=T6-T1). PSM matched TL and UT for preop demographics, scoliosis, PI-LL, TK, SVA, TPA and osteotomies. Postop deformity correction, complications, and PROs were compared for UT vs TL in L, M, S deformities.
Result(s): Of 699 eligible patients, 417 (L [n=70], S [n=166] and M [n=198]) were evaluated. UT and TL had similar preop age, frailty, spine deformity, follow up, osteotomies performed (p>0.05). UT had greater blood loss in L and M deformities, greater SICU admissions for L and S, longer hospital and greater revision surgery for implant failures for all deformities than TL (p<0.05). UT had fewer PJF for L deformities (p<0.05). Deformity correction and PROM improvement was similar UT vs TL for all cohorts at last follow up (p>0.05).
Conclusion(s): The theoretical benefits of UT fusion were not demonstrated for matched L, S and M patients receiving long fusion to the pelvis. UT had greater blood loss, hospital stay and revision surgery for implant failures than TL. For select deformities surgeons should consider TL UIV rather than UT; however, more research is needed to determine best outcomes for fusion levels for ASD. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Few studies investigate fractional curve correction after long fusion with transforaminal (TLIF) vs anterior lumbar interbody fusion (ALIF) for adult symptomatic thoracolumbar/lumbar scoliosis (ASLS). PURPOSE: Our objective was to compare fractional correction, health-related quality-of-life (HRQL), and complications associated with L4-S1 TLIF vs ALIF in ASLS operative treatment. STUDY DESIGN/SETTING: Retrospective review of a prospectively collected multicenter consecutive case registry. PATIENT SAMPLE: Database enrollment required age >=18 years, scoliosis >=20, sagittal vertical axis (SVA) >=5cm, pelvic tilt >=25, or thoracic kyphosis >=60. OUTCOME MEASURES: Radiographic correction (including L4-S1 fractional curve), HRQL (Oswestry Disability Index [ODI], Short Form-36 [SF-36] scores, Scoliosis Research Society-22 [SRS-22r] scores), and complications.
METHOD(S): Prospective multicenter data was reviewed. Study inclusion required fractional curve >=10degree, thoracolumbar/lumbar curve >=30degree, index TLIF vs ALIF at L4-L5 and/or L5-S1, and minimum 2-year follow-up. TLIF and ALIF patients were propensity-matched using number and type of interbody fusion at L4-S1.
RESULT(S): Of 135 potentially eligible consecutive patients, 106 (78.5%) achieved minimum 2-year follow-up (age=60.6+/-9.3years, women=85.8%, TLIF=44.3%, ALIF=55.7%). Index operations had 12.2+/-3.6 posterior levels, iliac fixation=86.8%, and TLIF/ALIF at L4-L5 (67.0%) and L5-S1 (84.0%). ALIF had greater cage height (10.9+/-2.1 vs 14.5+/-3.0mm, p=0.001) and lordosis (6.3degree+/-1.6degree vs 17.0degree+/-9.9degree, p=0.001) and longer operative duration (6.7+/-1.5 vs 8.9+/-2.5hrs, p<0.001). Final alignment improved significantly (p<0.05): fractional curve (20.2degree+/-7.0degree to 6.9degree+/-5.2degree), maximum coronal Cobb (55.0degree+/-14.8degree to 23.9degree+/-14.3degree), C7-sagittal vertical axis (5.1+/-6.2 to 2.3+/-5.4cm), pelvic tilt (24.6degree+/-8.1degree to 22.7degree+/-9.5degree), and lumbar lordosis (32.3degree+/-18.8degree to 51.4degree+/-14.1degree). Matched analysis demonstrated comparable fractional correction (TLIF=-13.6degree+/-6.7degree vs ALIF=-13.6degree+/-8.1degree, p=0.982). Final HRQL improved significantly (p<0.05): ODI (42.4+/-16.3 to 24.2+/-19.9), SF-36 Physical Component Summary (PCS, 32.6+/-9.3 to 41.3+/-11.7), SRS-22r (2.9+/-0.6 to 3.7+/-0.7). Matched analysis demonstrated worse ODI (30.9+/-21.1 vs 17.9+/-17.1, p=0.017) and PCS (38.3+/-12.0 vs 45.3+/-10.1, p=0.020) for TLIF at last follow-up (despite no difference in these parameters at baseline). Total complication rate per patient was not different (TLIF=76.6% vs ALIF=71.2%, p=0.530), but significantly more TLIF patients had rod fractures (RF) (TLIF=28.6% vs ALIF=7.1%, p=0.036). Multiple regression demonstrated 1-mm increase in L4-L5 TLIF cage height lead to 2.2degree reduction in L4 coronal tilt (p=0.011), and 1degree increase in L5-S1 ALIF cage lordosis lead to 0.4degree increase in L5-S1 segmental lordosis (p=0.045).
CONCLUSION(S): Operative ASLS treatment with L4-S1 TLIF vs ALIF demonstrated comparable fractional curve correction (66.7% vs 64.8%) despite significantly larger, more lordotic ALIF cages. TLIF cage height had significant impact on leveling L4 coronal tilt, whereas ALIF cage lordosis had significant impact on lumbosacral lordosis restoration. Advantages of TLIF may include reduced operative duration; however, associated HRQL was inferior and more RFs were detected in this study. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Since circumferential adult spinal deformity (ASD) surgery can lead to high surgical burden for the patient, surgeons may elect to stage these procedures during the same hospitalization. As a result, there is a trend toward planning same-hospitalization staged ASD surgeries by performing an anterior lumbar interbody fusion (ALIF) prior to a subsequent staged posterior fusion. PURPOSE: The aim of this study was to determine optimal timing for staging (early vs delayed) thoracolumbar ASD surgery within the same hospitalization. STUDY DESIGN/SETTING: Retrospective review of a multicenter database. PATIENT SAMPLE: A total of 158 surgical ASD patients undergoing anterior and staged posterior spinal fusion >=5 levels. OUTCOME MEASURES: Our outcome measures were 90-day complication rates, postoperative alignment, and 2-year ODI.
METHOD(S): Using a prospective, multicenter database, we identified 158 surgical ASD patients undergoing first an anterior surgery followed by a staged posterior spinal fusion >=5 levels during the same hospitalization. Stratum-specific likelihood ratio (SSLR) analysis was performed to calculate a cutoff point beyond which 90-day complications were increased. The cutoff generated through SSLR were confirmed with multivariable logistic regression analysis controlling for age, gender, levels fused for each stage, preoperative alignment, three-column osteotomy, and Charlson Comorbidity Index. The outcome measures were 90-day complication rates, postoperative alignment, and 2-year ODI. Multivariable analyses were performed with logistic, Poisson and linear regressions where appropriate.
RESULT(S): Utilization of staged procedures increased 4x from 2008-2019, and the mean staging interval was 3 days (range 1-8). On SSLR analysis, patients were divided into two staging categories based on complication risk: early (<6 days, range 1-5, N=139) versus delayed (>= 6 day, range 6-8, N=19). On bivariate analysis, the delayed group had higher 90-day complication rates (68.4% vs 32.4%, p=0.002) and longer operative times (638 min vs 739 min, p=0.020) relative to the early group. Adjusting for covariates on multivariable analysis, patients with delayed staging had significantly greater odds of 90-day complications (OR=7.57, p=0.006), and longer total operative time (beta=119, p=0.035). With respect to specific complications, delayed staging carries increased odds of infection compared to early staging (OR=11.8 p=0.031). There were no significant differences in postoperative alignment or 2-year ODI between the groups (p>0.05 for all).
CONCLUSION(S): Compared to early staging (< 6 days) of ALIF and subsequent staged posterior fusion, delayed staging (>= 6 days) is associated with greater odds of 90-day complications, particularly infection. With the growing trend toward staged ASD surgeries, efforts should be made to shorten the interval between ALIF and subsequent posterior fusion. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Rod failure and pseudarthrosis are common complications following the surgical treatment of adult spinal defomity (ASD). Many strategies have been employed in mitigating these problems, such as interbody fusion, multiple rods, use of more effective biologics, and optimizing spinal alignment. We aimed to study the frequency and type of rod failures in a large ASD population over time. PURPOSE: To study the frequency and type of rod failures in a large ASD population over time. STUDY DESIGN/SETTING: Retrospective review of prospective data. PATIENT SAMPLE: This study included 647 adult spinal deformity patients surgically treated between 2008 and 2018. OUTCOME MEASURES: Rod failures.
METHOD(S): ASD patients with a fusion extended from minimum L1 to pelvis and min 2-year follow-up were included. Radiographs and records were examined to identify characteristics of the rod failures: timing, unilateral vs bilateral, vertebral level, unilateral progressing to bilateral failure, revision and failure rates over time.
RESULT(S): Among the study population, 647/1052 patients met inclusion criteria (age: 64+/-10 yrs., 78% F, BMI: 28.3+/-5.7, Mean follow-up: 37 months +/-13). Surgeries for these patients were performed from 2008 to 2018. The UIV was T7 or above in 306 and T8 or below in 338 patients, most frequent UIV: T4 (121) and T10 (208). A total of 146 patients had a 3COs; 435 had interbody fusion with 187 ALIF, 202 TLIF,135 XLIF; 286 patients had BMP use post only and 203 had BMP use interbody and posteriorly. Overall rod failure rate was 135/647 (21%), of which 9.3% occurred before by 2 years postop. Mean days to failure was 795 day +/- 485 (Median 733). Most frequent failures were in the lower lumbar spine L3-4 (32) 24%, L4-5 (34) 25% and L5-S1 (44) 32%. Of the 97 Unilateral failures, 35 (36.1%) were revised and only 8 progressed to bilateral failure of which 6/8 were revised; 46 Bilateral failure, 24 (52.2%) were revised.Kaplan-Meier analysis shows a survival rate of 89.7% at 2 years with decrease of 5% per year. No significant difference was found between the first 5 years and last 5 years. Comparison of primary vs revision index procedures did not reveal any differences in time to failure nor time to revision. Use of BMP improved survival rate to 91.2% compared to no BMP 83.4% at 2 years.
CONCLUSION(S): Rod failures remain a common complication when treating ASD with a rate of 21%. Among those rod failures, 9.3% occurred within 2 years. The most frequent sites of failure were in the lower lumbar spine. Unilateral failures underwent a lower rate of revision than bilateral. BMP increased rod survivability. Kaplan-Meier analysis demonstrated a survival rate of 89.7% at 2 years with a decrease of 5% per year. The failure rate has not improved when comparing the first 5 years. to last 5 years. We must continue to seek solutions to improve rod durability challenges to improve long-term outcomes. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright